Compare AP & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AP | ANIK |
|---|---|---|
| Founded | 1929 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.5M | 200.9M |
| IPO Year | 2018 | 1996 |
| Metric | AP | ANIK |
|---|---|---|
| Price | $7.69 | $20.93 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 78.8K | ★ 95.2K |
| Earning Date | 11-11-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.16 |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $434,166,000.00 | $112,819,000.00 |
| Revenue This Year | N/A | $7.82 |
| Revenue Next Year | $3.52 | $5.44 |
| P/E Ratio | $279.67 | ★ N/A |
| Revenue Growth | ★ 3.79 | N/A |
| 52 Week Low | $1.75 | $9.01 |
| 52 Week High | $12.81 | $22.88 |
| Indicator | AP | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 40.14 | 52.85 |
| Support Level | $7.47 | $20.13 |
| Resistance Level | $8.95 | $22.70 |
| Average True Range (ATR) | 0.52 | 0.67 |
| MACD | -0.05 | 0.12 |
| Stochastic Oscillator | 15.76 | 53.98 |
Ampco-Pittsburgh Corp manufactures and sells engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. It operates in two business segments, namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, & other metals. The Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, & Buffalo Pumps. The company generates a majority of its revenue from the Forged & Cast Engineered Products segment. It has a business presence in the United States & other countries.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.